Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
InMed To Participate At Virtual Conferences In January 2021
By PR Newswire
Jan 5, 2021 4:52 PM EST
PRESS RELEASES
InMed Announces Results Of Initial Phase 1 Clinical Trial Of INM-755 CBN Cream In Healthy Subjects
By PR Newswire
Nov 25, 2020 7:30 AM EST
PRESS RELEASES
InMed Pharmaceuticals And BayMedica Announce Collaboration For Manufacturing And Testing Of Novel Cannabinoid Therapeutics
By PR Newswire
Nov 18, 2020 7:30 AM EST
PRESS RELEASES
InMed Pharmaceuticals Announces The Closing Of US$8 Million Public Offering
By PR Newswire
Nov 16, 2020 11:42 AM EST
PRESS RELEASES
InMed Announces Pricing Of US$8M Public Offering And Listing On The Nasdaq Capital Market Under The Symbol "INM"
By PR Newswire
Nov 12, 2020 9:10 AM EST
